Novo Nordisk Archives | the deep dive

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Novo Nordisk

$450 Error Nukes Novo Nordisk’s Ozempic Patent, Opening Canada To Generics

Big Food Scrambles to Adapt as Weight Loss Drugs Transform Appetites

Study Examines Vision Loss Reports in Patients Taking GLP-1 Drugs

Novo Nordisk Shares Surge After Next-Gen Obesity Drug Shows 22% Weight Loss

People Are Overdosing On Ozempic and Its Off-Brand Versions

Can Ozempic Topple Fast Food Demand?

Denmark’s GDP Gets A Big Boost From Ozempic

Is Ozempic the New Wonder Drug?

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Alta Copper Gets Acquired: Were Shareholders Robbed?

NexGen Launches 42,000 Metre Drill Program At PCE While Expanding Mineralized Footprint

First Majestic Hits 2025 Guidance, Producing 31.1 Million Silver Equivalent Ounces, Increases Dividend